BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Pharming Group N.V. (PHAR) investor events
X-WR-CALNAME:Pharming Group N.V. (PHAR) investor events
DESCRIPTION:Earnings calls and investor events for Pharming Group N.V. (PHA
 R)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Pharming Group N.V. (PH
 AR)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:b75f01f3-c14d-4118-ad6c-966186497c13@equibles.com
DTSTAMP:20260929T020628Z
DTSTART;VALUE=DATE:20260312
DTEND;VALUE=DATE:20260313
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Pharming Group N.V. (PHAR) Earnings Call\, FY2025 Q4
DESCRIPTION:The start time has not been announced.\nWebcast: https://edge.m
 edia-server.com/mmc/p/ddxigjqm
URL:https://equibles.com/stocks/phar/calls/2025-q4
END:VEVENT
BEGIN:VEVENT
UID:75973be3-e544-4779-a290-32399663883d@equibles.com
DTSTAMP:20260611T030049Z
DTSTART;VALUE=DATE:20260507
DTEND;VALUE=DATE:20260508
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Pharming Group N.V. (PHAR) Earnings Call\, FY2026 Q1
DESCRIPTION:The start time has not been announced.\nWebcast: https://edge.m
 edia-server.com/mmc/p/topu6hc2/
URL:https://equibles.com/stocks/phar/calls/2026-q1
END:VEVENT
BEGIN:VEVENT
UID:8cd837b5-4840-40c9-8168-afb2d7fdc65a@equibles.com
DTSTAMP:20260730T104526Z
DTSTART;VALUE=DATE:20260730
DTEND;VALUE=DATE:20260731
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Pharming Group N.V. (PHAR) Earnings Call\, FY2026 Q2
DESCRIPTION:The start time has not been announced.\nWebcast: https://edge.m
 edia-server.com/mmc/p/m35zejc7
URL:https://equibles.com/stocks/phar/calls/2026-q2
END:VEVENT
BEGIN:VEVENT
UID:6309186b-8a47-4655-8e0c-5998702a6720@equibles.com
DTSTAMP:20260909T193655Z
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260915
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Pharming Group N.V. (PHAR) Conference: H.C. Wainwright 28th Annual 
 Global Investment Conference
DESCRIPTION:H.C. Wainwright 28th Annual Global Investment Conference\nThe s
 tart time has not been announced.\nWebcast: https://journey.ct.events/view
 /e927a8f9-64a7-4c0e-9665-25955c4beee1
URL:https://equibles.com/stocks/phar/events/6309186b-8a47-4655-8e0c-5998702
 a6720
END:VEVENT
BEGIN:VEVENT
UID:fbc32d62-9db1-4039-89d7-560f82d508e6@equibles.com
DTSTAMP:20260914T214928Z
DTSTART;VALUE=DATE:20260915
DTEND;VALUE=DATE:20260916
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Pharming Group N.V. (PHAR) Conference: Morgan Stanley 24th Annual G
 lobal Healthcare Conference
DESCRIPTION:Morgan Stanley 24th Annual Global Healthcare Conference\nThe st
 art time has not been announced.\nWebcast: https://www.pharming.com/files/
 pharming-corporate-overview-september-2026-website.pdf
URL:https://equibles.com/stocks/phar/events/fbc32d62-9db1-4039-89d7-560f82d
 508e6
END:VEVENT
BEGIN:VEVENT
UID:94b0c34c-4656-4781-96dd-589f3c83bedd@equibles.com
DTSTAMP:20261022T164127Z
DTSTART;VALUE=DATE:20261027
DTEND;VALUE=DATE:20261028
SEQUENCE:25461687
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Pharming Group N.V. (PHAR) Earnings Call\, FY2026 Q3
DESCRIPTION:The start time has not been announced.\nWebcast: https://edge.m
 edia-server.com/mmc/p/nnjperkk
URL:https://equibles.com/stocks/phar/calls/2026-q3
END:VEVENT
END:VCALENDAR
